Cointime

Cambridgene

company

About

Cambridgene is provides robust multi-omic analytics workflows and access to novel clinical genomic data to accelerate clinical research.

  • 1 - 10

Highlights

Funding Rounds
1
Investors
1

Details

Last Funding Type
Seed
Industries
Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Cambridgene unlocks the power of multi-omics to accelerate and de-risk pharmaceutical research and development. Their advanced clinical research workflows and genetic profiling solutions accelerate the development and delivery of precision medicines.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
—
Cambridgene has raised a total of — in funding over 2 rounds. Their latest funding was raised on Apr 18, 2019 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 18, 2019 Seed — 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Cambridgene is funded by 1 investors. 500 Global are the most recent investors.
Investor Name Lead Investor Funding Round
500 Global — Seed
Cointime
เนื้อหา
บริษัท